Human Molecular Genetics · 2016 · 62 citations · 42 references
Life SciencesNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurochemistryGlutamatergic NeurochemistryHuntington DiseaseN-acetylcysteine TherapyNeurotransmissionNeurotransmitter MetabolismSynaptic TransmissionAntidepressant EfficacyAntidepressant ResponseCysteine MetabolismGlutamate Homeostasis DisruptionGlutamate MetabolismGlutamate NeurotransmissionGlutamatergic DysfunctionTransgenic Mouse Models
and GLT-1 inhibitors CPG and DHK, showing that glutamate transporter activity was required for the antidepressant effects of NAC. NAC was also able to specifically increase glutamate in HD mice, in a glutamate transporter-dependent manner. These in vivo changes reflect changes in glutamate transporter protein in HD mice and human HD post-mortem tissue. Furthermore, NAC was able to rescue changes in key glutamate receptor proteins related to excitotoxicity in HD, including NMDAR2B. Thus, we have shown that baseline reductions in cysteine underlie glutamatergic dysfunction and depressive-like behavior in HD and these changes can be rescued by treatment with NAC. These findings have implications for the development of new therapeutic approaches for depressive disorders.
42
Depression: a new animal model sensitive to antidepressant treatments
Roger D. Porsolt, Manuel Pichon, M Jalfre · Nature · 1977 · 4.4K citations
Medicine, Neuroscience, Psychiatry +12